Open in new window
Featured News
|
Photys Therapeutics and with Novo Nordisk to Develop Induced Proximity PHICS TechnologyUnder the terms of the agreement, Photys is eligible to receive up to USD 186 million in upfront, development and commercial milestone payments, in addition to R&D funding and tiered royalty payments... Read more |
|
Steriline Strengthens its Presence in Ophthalmic IndustryTubilux Pharma has chosen the Steriline ophthalmic line to fill glass and plastic vials with eye drops and freeze-dried products, with the aim of increasing production capacity while being fully compliant... Read more |
|
LOG Launches Modern Clean Room to Advance Pharmaceutical Packaging SolutionsThis new multi-million-dollar facility is part of a broader 600-square meter expansion of LOG's manufacturing site in Kibbutz Ashdot Ya'acov Ichud, Israel. Read more |
|
MOBILion Systems Launches New Mass Spectrometry Functionality for Proteomics WorkflowsIn a white paper titled ‘Abandoning the Quadrupole for Mass Spectrometry Fragmentation Analysis’, MOBILion reveals how harnessing the game-changing capabilities of its proprietary structures... Read more |
|
MD Logistics to Launch Dedicated Pharmaceutical Warehouse in IndianaThe warehouse undergoing renovations is the largest in MD's network at approximately 37,000 m2. Read more |
|
Agilent Announces Acquisition of BIOVECTRAWith the addition of BIOVECTRA, Agilent will expand its portfolio of CDMO services, add rapidly growing modalities, and bring world-class capabilities to support gene editing. Read more |
Pharmaindustrial News
|
Akums Signs INR 1,760 Crore CDMO Deal with a Global Pharma CompanyAkums group will manufacture and supply multiple SKUs of oral liquid formulation to be marketed in multiple European countries by the company. Read more |
|
Ractigen Therapeutics Doses First Patient in Phase I Clinical Trial for RAG-17 in SOD1-ALSRAG-17 received Orphan Drug Designation (ODD) from the US Food and Drug Administration (FDA) in March 2023, followed by the FDA's clearance of its Investigational New Drug (IND) application. Read more |
|
Porton Pharma Solutions and Dragon Sail Pharmaceutical Partner to Advance ADC Drug EcosystemThis collaboration aims to carry out in-depth cooperation in the research, development, production, and supply chain integration of antibody-drug conjugates (ADC). Read more |
|
TekniPlex Healthcare Emphasizes Two EU-Based Capacity and Capabilities Expansions at Pharmapack EuropeAt Stand E97 , the company will highlight its efforts to meet growing demand for sophisticated vials, bellow bottles and cleanroom-produced multilayer blown films, and also showcase products from... Read more |
|
OBI Pharma Partners with GlyTech to Promote GlycOBI Enabling Technologies Outreach in JapanUnder the terms of the Material Transfer Agreement, OBI will transfer some of its cutting-edge materials to GlyTech for research in advancing the efficient production of glycans for ADCs. Read more |
|
Neuraxpharm and Pharmathen to Co-Develop Long-Acting Injectable TherapiesUnder this agreement, Neuraxpharm will have exclusive rights to commercialise these therapies in Europe, and in countries outside of Europe where the group has a direct presence, while Pharmathen... Read more |
|
HKBU's Aptamer for Rare Bone Disease Receives Orphan Drug and Rare Pediatric Disease Designations by FDAThe aptamer, originally developed to treat osteogenesis imperfecta, has been granted Orphan Drug Designation and Pediatric Rare Disease Designation by the US Food and Drug Administration (FDA). Read more |
|
MTPA Signs Deal with Dewpoint to Advance Small Molecule Condensate ModulatorThe collaboration focuses on developing a novel TDP-43 small molecule condensate modulator (c-mod) for amyotrophic lateral sclerosis (ALS), furthering MTPC's commitment to advancing innovation in... Read more |
|
Noema Pharma Closes its Series B Financing Round with USD 147 Million Capital FundingThe new financing will support Noema Pharma’s four active Phase 2 trials, with key data readouts anticipated in 2025. Read more |
|
Lilly and EVA Pharma Secure Approval to Distribute Locally Manufactured Insulin in EgyptUnder this agreement, Lilly has been supplying its active pharmaceutical ingredient (API) for insulin to EVA Pharma at a significantly reduced price and providing pro-bono technology transfer to enable... Read more |
|
AbbVie to Acquire Nimble Therapeutics to Expand its Immunology PipelineAbbVie will acquire Nimble's peptide synthesis, screening, and optimization platform, which uses proprietary technology to help drive rapid discovery and optimization of peptide candidates for a range... Read more |
|
VectorY Welcomes Jim Scibetta as New CEOScibetta brings more than 20 years of executive leadership experience, having built earlier stage companies focused on developing novel therapeutics for high unmet medical needs into mature biotechnology... Read more |
|
CPHI Milan Records 59,000 Visitors from Pharma IndustryThe event’s success is widely used as a proxy for overall growth in global pharma in the year ahead, with attendance up 9 percent on 2023 and a remarkable 45 percent over the last two years. Read more |
|
Gland Pharma Gets FDA Approval for Phytonadione Injectable EmulsionThe product is bioequivalent and therapeutically equivalent to the reference listed drug (RLD), Vitamin KI1 Injectable Emulsion USP, 10 mg/mL, of Hospira, Inc. Read more |
|
Glenmark Introduces Lacosamide Oral SolutionGlenmark’s Lacosamide Oral Solution, 10 mg/mL is bioequivalent and therapeutically equivalent to the reference listed drug, Vimpat Oral Solution, 10 mg/mL of UCB, Inc. Read more |
|
Asahi Kasei Pharma Signs Exclusive License Deal for Anti-CX3CR1 AntibodyThe anti-CX3CR1 antibody, currently in preclinical development, works by inhibiting CX3CR1, a receptor involved in immune cell migration to inflammatory sites. Read more |
|
Endo Secures FDA Approval for its Manufacturing Facility in IndoreThe Indore facility is designed specifically for aseptic manufacturing of sterile injectable products—a difficult and highly specialized production capability. Read more |
|
Skyhawk Gets Australian Regulatory Approval to Extend SKY-0515 Treatment DurationHREC also agreed to the inclusion of Volumetric MRI (vMRI) measurements as an early exploratory endpoint in the trial. Read more |
|
SSI Mantra Becomes India's First CDSCO Certified Robotic System for TelesurgeryThis landmark achievement positions SSI Mantra as the first surgical robotic system in India authorized to perform these advanced capabilities. Read more |
|
Tower Cold Chain and CCT to Expand its Global Reach with Integrated Hub NetworkWith the combined resources of Tower and CCT, customers now benefit from a vastly expanded hub network featuring three Centres of Excellence and 54 regional hubs spanning 26 countries, enabling broader... Read more |
|
Suven Pharma to Acquire Stake in NJ Bio with Investment of USD 64.4 MillionNJ Bio has served 150+ customers, delivered over 500 projects in 5 years, and won the prestigious World ADC Awards for four consecutive years. Read more |
|
Alembic Pharma Gets Tentative Approval for Olopatadine Hydrochloride Ophthalmic SolutionOlopatadine Hydrochloride Ophthalmic Solution USP, 0.7 percent (OTC) has an estimated market size of USD 22 million for twelve months. Read more |
|
Getinge Opens New Experience Center in MumbaiThe Experience Center showcases Getinge's innovative solutions, including the Getinge IN2 OR Modular Room System, designed to meet the evolving needs of modern surgery. Read more |
|
Orbit Discovery, Evergreen Theragnostics Expand Research Alliance to Boost Targeted Therapeutics DevelopmentThe expanded collaboration will leverage Orbit Discovery’s proprietary screening platform to identify and optimize peptide candidates, combined with Evergreen Theragnostics’ expertise... Read more |
|
Ampersand Capital Partners Launches Newly Branded Business Gannet BioChemThe new Ampersand portfolio company will be branded Gannet BioChem and will continue to operate out of its state-of-the-art facility in Huntsville, Alabama. Read more |
|
Roche Announces Acquisition of Poseida TherapeuticsThe proposed acquisition will establish a new core capability for Roche in allogeneic cell therapy, with lead opportunities focused on CAR-T programs covered by the existing strategic collaboration... Read more |
|
Lupin Gets Tentative Approval from FDA for Sitagliptin and Metformin Hydrochloride TabletsSitagliptin and Metformin Hydrochloride Tablets, 50 mg/500 mg and 50 mg/1000 mg are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. Read more |
|
ASPA Promotes Members' Anti-Counterfeiting Solutions GloballyIn his address, Puneet highlighted ASPA's growing global presence and its strategic efforts to fight counterfeiting by promoting the innovative anti-counterfeiting solutions offered by its members... Read more |
|
MGI Tech Partners with Universidad de San Martin de Porres to Boost Human Genetics ResearchThis advancement will enable the identification of genetic risk factors in the population for the development of future public health treatments. Read more |
|
CORONA Remedies to Launch its New Hormonal Products Manufacturing Plant in AhmedabadCommercial production is expected to commence in FY 2026, marking a significant step forward in CORONA’s commitment to women’s healthcare. Read more |
|
CPHI & PMEC India 2024 Showcases Pharma Industry Innovation and Global ReachSpanning pharma machinery, packaging, analytical instruments, laboratory technologies, ingredients, and beyond, CPHI & PMEC India 2024 offers a comprehensive platform for stakeholders to engage... Read more |
|
Adragos Pharma Acquires Baccinex to Expand its Sterile Manufacturing ServicesThe acquisition of Baccinex aligns seamlessly with Adragos’ strategy to build a world-class manufacturing network that provides tailored solutions to meet the evolving needs of its customers. Read more |
|
SS Innovations Performs Indonesia's First Robotic Cardiac SurgeryThis achievement showcases the capabilities of SSI Mantra Surgical Robotic System and reflects Dr. Srivastava's leadership, blending his entrepreneurial vision with surgical expertise. Read more |
|
Glenmark Rolls Out Travoprost Ophthalmic SolutionGlenmark’s Travoprost Ophthalmic Solution USP, 0.004 percent is bioequivalent and therapeutically equivalent to the reference listed drug, Travatan Z Ophthalmic Solution USP, 0.004 percent of... Read more |
|
Freudenberg to Showcase Pioneering Solutions at CPHI & PMEC 2024Freudenberg Medical recently announced the PharmaFocus Premium ASTC UV-Shield Tubing, which is specifically intended for photosensitive pharmaceuticals and has a platinum-cured silicone interior and... Read more |
|
Lonza Completes its First GMP Batch of Next-Gen Mammalian Manufacturing Facility in USThe first GMP batch release marks a significant milestone, allowing the facility to help meet the increasing market demand for small- to mid-scale volumes of mammalian-derived biologics and support... Read more |
|
Johnson & Johnson Submits FDA Approval for SC Induction Regimen of TREMFYA in Ulcerative ColitisTREMFYA® is the first and only approved, dual-acting monoclonal antibody that blocks IL-23 while also binding to CD64, a receptor on cells that produce IL-23. Read more |
|
Boehringer Ingelheim Unveils VETMEDIN SolutionVETMEDIN Solution, now available in the US, provides the same dual mode of action as VETMEDIN® Chewable Tablets. Read more |
|
Gattefosse Launches New Technical CoE in MumbaiThe Technical Center of Excellence aims to support local customers and generate innovative applications for Gattefossé excipients based on an informed perception of Indian, regional, and global... Read more |
|
Siegfried Opens New Global R&D Center for Drug Substances in SwitzerlandTogether with the R&D Center in Zofingen, it will offer chemical process R&D and analytical development services for Siegfried’s global Drug Substances network. Read more |
|
Epigenic Therapeutics to Initiate Clinical Development of EPI-003This first-in-human study will assess the safety, tolerability, pharmacokinetics (PK), and pharmacodynamics (PD) of EPI-003 in Nucleos(t)ide Analogue-Treated, Chronic Hepatitis B Patients. Read more |
|
Tata Elxsi, DENSO and AAtek Launch Robotics and Automation Innovation Lab in FrankfurtThis state-of-the-art facility aims to drive the future of robotics automation across sectors such as medical devices, pharmaceuticals, life sciences and food science. Read more |
|
Ractigen Therapeutics Secures FDA Orphan Drug Designation for RAG-21RAG-21 is an siRNA therapy specifically designed to target FUS-ALS, one of the most aggressive subtypes of ALS. Read more |
|
Abbott Inaugurates New Global Manufacturing Facility in IrelandThe Kilkenny facility is part of a EUR 440 million investment in Ireland, which includes a significant expansion of the company’s Donegal site, where a further 200 jobs are being created. Read more |
|
Telix Plans to Add FAP-Targeting Candidates to Theranostic PipelineTelix has entered into asset purchase and exclusive worldwide in-licence agreements for a suite of clinically validated FAP-targeting therapeutic and precision medicine (diagnostic) radiopharmaceutical... Read more |
|
AbbVie Receives European Commission Approval of ELAHEREELAHERE is the first and only folate receptor alpha (FR?)-directed antibody drug conjugate (ADC) medicine approved in the European Union (EU), as well as Iceland, Liechtenstein, Norway, and Northern... Read more |
|
Acumen Pharmaceuticals Appoints New Chief Regulatory Officer and Head of QualityDr. Schacterle brings over 30 years of experience in regulatory affairs, quality assurance, and therapeutic development to Acumen, with a focus on diseases of the central nervous system. Read more |
|
Syndax Signs USD 350 Million Royalty Funding Deal with Royalty Pharma for NiktimvoUnder the terms of the agreement, Syndax received an upfront payment of USD 350 million in exchange for a 13.8 percent royalty on US net sales of Niktimvo. Read more |
|
Scorpius Teams Up with Celltheon to Offer Affordable BiotherapeuticsThis collaboration enables clients to integrate with Scorpius’ program management team and quality system while preparing to transfer a research cell bank (RCB) to the company’s facilities... Read more |
|
Gland Pharma Reports Revenue of INR 14,058 Million in Q2FY25Gland Pharma has reported a consolidated revenue of INR 14,058 million for Q2 FY25, marking a 2 percent increase compared to INR 13,734 million in Q2 FY24. Read more |
|
Abzena Expands its Microbiology Laboratory Space for Biologic ManufacturingThe expansion of the QC microbiology lab is part of Abzena's broader strategy to help alleviate and address the market demand for quality testing, which has been driven by increased regulatory requirements,... Read more |
|
Syntegon and Abzil Close Acquisition of TelstarThe Telstar workforce will now join the Syntegon team in the Pharma Liquid Business Unit. Read more |
|
AbbVie and EvolveImmune to Develop Next-Gen Cancer BiotherapeuticsEvolveImmune's proprietary EVOLVE platform is designed to deliver potent, selective and integrated T-cell co-stimulation to amplify and sustain the tumor killing capacity of the T-cells. Read more |
|
SwRI Breaks Ground of New 21,000-Sq. Foot Clinical Supply FacilitySwRI’s Rhodium docking platform accelerates the drug discovery process by screening millions of compounds to identify the best potential candidates. Read more |
|
Samsung Biologics Inks Manufacturing Deal with Asian Pharmaceutical CompanyWith the latest agreement, the company's accumulated contract for 2024 surpasses USD 3.3 billion. Read more |
|
Lupin Announces Appointment of Claus Jepsen as President-Global SpecialtyClaus joins Lupin from Takeda Pharmaceuticals, where he led the Global Strategy for Rare Diseases. Read more |
|
Alembic Pharma Secures FDA Approval for Diltiazem Hydrochloride CapsulesThe approved ANDA is therapeutically equivalent to the reference listed drug product (RLD), Dilacor XR Extended-Release Capsules, 120 mg, 180 mg, and 240 mg, of Allergan Sales LLC (Allergan). Read more |
|
Informa Markets Announces 17th Edition of CPHI and PMEC India Expo in NovemberThe CPHI & PMEC India Expo 2024 promises to be a transformative event for the pharmaceutical sector, bringing together over 50,000 industry professionals and 2,000 exhibitors, who will present... Read more |
|
Gland Pharma Welcomes Shyamakant Giri as New CEOGiri is a business leader with over 25 years of strategic and operating experience in pharmaceuticals, devices, diagnostics and healthcare services in Indian and multinational organizations across... Read more |
|
Factor Bioscience Signs Exclusive License Deal with Eterna TherapeuticsThe agreement positions both companies with the potential to accelerate the development of advanced cell therapies in the oncology, rare disease, and autoimmune fields. Read more |
|
Eximia Research Acquires Integrated Clinical Trial ServicesWith this expansion into Iowa, this partnership marks another significant milestone in Eximia's mission to broaden access to cutting-edge clinical trials and innovative healthcare solutions across... Read more |
|
VGXI Picks Cryoport to Support its Supply Chain Solutions to Boost Next-Gen TherapiesVGXI is a contract developer and manufacturer specializing in nucleic acid biopharmaceuticals, including gene therapies, DNA vaccines and RNA medicines, and ADC applications. Read more |
|
OneSource Secures Equity Commitments of USD 95 Million for FundraisingThe strong interest from leading investors reflects growing confidence in our capabilities and the immense potential of the CDMO sector emerging out of India. Read more |
|
Lupin Introduces First Generic Version of Pred Forte in USBeing the first generic to be approved and launched, the company is entitled to 180-day competitive generic therapy (CGT) exclusivity. Read more |
|
LGM Pharma Expands Analytical Testing Services with New ServicesThese new services, now available at LGM Pharma’s Irvine, CA, facility, offer significant benefits to drug developers, including accelerated turnaround times, enhanced quality control, and cost... Read more |
|
Lundbeck to Acquire Longboard Pharmaceuticals to Expand its Neuroscience PipelineUnder the terms of the agreement, Lundbeck will commence a tender offer for all outstanding shares of Longboard common stock, whereby Longboard shareholders will be offered a payment of USD 60.00... Read more |
|
RedHill Biopharma Bags Funding Through BARDA to Advance Opaganib for Ebola TreatmentUnder this cost-sharing contract, BARDA will provide partial funding for the company to further advance opaganib to mitigate infection and contain EBOV outbreaks. Read more |
|
Akeso Receives USD 250 Million to Boost Global Expansion of its Drug PipelineSeventy percent of the financing will accelerate the global clinical development of innovative drugs developed internally by Akeso, with a primary focus on its core products in both China and international... Read more |
|
Aptar Pharma Acquires Device Technology Assets of SipNoseSipNose offers a variety of devices that are designed and adapted to fit a wide range of therapies and offer the opportunity to precisely target areas of the nasal cavity to enable enhanced systemic,... Read more |
|
Mankind Pharma Bags CCI Approval for BSV AcquisitionThe proposed transaction involves the acquisition of 100 percent shareholding of Bharat Serums and Vaccines Ltd. (BSV) by Mankind Pharma Ltd. Read more |
|
Biocon Biologics' Report Offers Insights on Increasing Biosimilars Adoption in LMICsBiocon Biologics commissioned the study, defined the methodology and collaborated with Clarivate to develop the final report. Read more |
|
Exothera Welcomes Cedric Volanti as New CEOCédric Volanti brings a wealth of experience and a strong strategic vision. Read more |
|
Innovent Partners with Ask Pharm for Limertinib for Treatment of Lung CancerUnder the agreement, Innovent will obtain the exclusive commercialization rights for limertinib in mainland China, and will be entitled to receive a commercialization service fee based on the product's... Read more |
|
OneSource Unveils New Brand Identity at CPHI MilanOneSource’s end-to-end offering across all its platforms was established in response to its customers’ need to streamline supply chains by consolidating their outsourcing partners. Read more |
|
Nipro Rolls Out D2F Glass Vials Leveraging Stevanato's EZ-fill TechnologyD2F glass vials offer a seamless ready-to-use (RTU) solution with their Direct-to-Fill technology. Read more |
|
OrbusNeich Opens High-Capacity Logistics Center in NetherlandsThe investment in the new warehouse is a response to increased production demands and the growing need for enhanced logistics and storage capabilities. Read more |
|
UCB Gets FDA Approval for BIMZELX for Treatment of Psoriatic ArthritisBIMZELX is the first approved treatment for these three indications that is designed to selectively inhibit two key cytokines driving inflammatory processes – interleukin 17A (IL-17A) and interleukin... Read more |
|
Antengene Receives Approval for XPOVIO for Commercialisation in ThailandThis successful approval for XPOVIO in Thailand will introduce novel therapies to the clinical management of patients with MM in Thailand, benefiting many patients and their families in the country. Read more |
|
Telix Announces Acquisition of RLS to Expand its North American Manufacturing FootprintThis acquisition of RLS is aligned with Telix's investment strategy around vertically integrated supply chain, manufacturing, and distribution, further enabling the delivery of future clinical and... Read more |
|
Axio BioPharma Introduces New Protein Manufacturing ServicesAxio BioPharma specializes in research-grade manufacturing of monoclonal antibodies (mAbs), focusing on small-scale production ranging from 50?mL to 2?L. Read more |
|
Suven Pharmaceuticals Announces Appointment of Vivek Sharma as Executive ChairmanVivek brings tremendous CDMO and leadership expertise to Suven, acquired across his roles as CEO of Piramal Pharma Solutions and as Chairman & CEO of Adare Pharma Solutions, a technology CDMO... Read more |
|
Lupin Gets FDA Approval for Bumetanide InjectionBumetanide Injection USP, 1 mg/4 mL (0.25 mg/mL) Single-Dose Vials and 2.5 mg/10 mL (0.25 mg/mL) Multiple-Dose Vials are indicated for the treatment of edema associated with congestive heart failure,... Read more |
|
Lupin and Takeda to Commercialize Vonoprazan in IndiaUnder the terms of this agreement, Takeda has granted Lupin non-exclusive patent licensing rights to commercialize Vonoprazan in India. Read more |
|
Indian Govt Approves Bio-RIDE Scheme to Accelerate R&D in BiotechnologyThe proposed outlay for the implementation of the unified scheme ‘Bio-RIDE’ is INR 9197 crore during the 15th Finance Commission period from 2021-22 to 2025-26. Read more |
|
Seran Bioscience Announces USD 200 Million Strategic Growth TransactionThe new facility will be completed in 2026 and will support oral, pulmonary, and nasal delivery modalities with commercial-scale particle engineering solutions, including spray drying, hot melt extrusion,... Read more |
|
Somite Therapeutics Receives FDA Orphan Drug and RPDD Designations for SMT-M01Somite Therapeutics' SMT-M01 program leverages the company's proprietary AlphaStem AI platform to develop a novel cell replacement therapy for DMD. Read more |
|
Strides Secures FDA Approval for Fluoxetine TabsWith the approval of the Fluoxetine Tabs 60 mg strength, the company is now positioned to offer a complete portfolio of Fluoxetine across Capsules and Tablets in 10 mg, 20 mg, and 60 mg strengths. Read more |
|
Zydus Signs Licensing and Supply Agreement with Viwit PharmaceuticalsAs per the terms of the agreement, Viwit will be responsible for ANDA submission, manufacturing and supplying the generic versions of GADAVISTTM and DOTAREM, following the receipt of requisite regulatory... Read more |
|
Refeyn Establishes New Mass Photometry Scientific Advisory BoardThe new Scientific Advisory Board will convene regularly to explore and evaluate the transformative potential of mass photometry in critical customer workflows. Read more |
|
Cellular Origins, 3P innovation to Advance Industrialisation of CGT Manufacturing3P innovation’s cryoFIL platform is designed to automate and streamline filling processes in cell and gene therapy workflows, incorporating the company’s proven technology within a cGMP-compliant... Read more |
Articles
|
Sustainable Solutions in Pharma Supply Chains: Reducing Carbon Footprint with Sustainable ExcipientsThe pharmaceutical industry is under increasing pressure to adopt more sustainable practices, especially when it comes to reducing the carbon footprint of supply... Read more |
|
Smart Pharma Packaging: Enhancing Efficiency and Reducing Waste, Combating CounterfeitingIn an industry as crucial as pharmaceuticals, where public health and safety are paramount, innovation is no longer a choice; it’s a necessity. As global... Read more |
|
From Certification to Contracts: How Indian Pharma Companies Can Enter EU Market?Indian pharmaceutical industry occupies world’s third largest seat in accordance to the volume of production and plays a significant role globally. Being... Read more |
|
|
From Certification to Contracts: How Indian Pharma Companies Can Enter EU Market?Indian pharmaceutical industry occupies world’s third largest seat in accordance to the volume of production and plays a significant role globally. Being... Read more |
|
The Counterfeit Crisis: A Call to Action for the Pharmaceutical IndustryIn today’s rapidly advancing technological landscape, the pharmaceutical industry is confronted with a critical challenge: counterfeit drugs. While innovations... Read more |
|
|
The Counterfeit Crisis: A Call to Action for the Pharmaceutical IndustryIn today’s rapidly advancing technological landscape, the pharmaceutical industry is confronted with a critical challenge: counterfeit drugs. While innovations... Read more |
|
|
The Counterfeit Crisis: A Call to Action for the Pharmaceutical IndustryIn today’s rapidly advancing technological landscape, the pharmaceutical industry is confronted with a critical challenge: counterfeit drugs. While innovations... Read more |
|
|
The Counterfeit Crisis: A Call to Action for the Pharmaceutical IndustryIn today’s rapidly advancing technological landscape, the pharmaceutical industry is confronted with a critical challenge: counterfeit drugs. While innovations... Read more |
|
Empowering India's Pharma Industry: The Strategic Impact of PLI InitiativesIn recent years, India's pharmaceutical industry has undergone a remarkable transformation, fueled by the implementation of Production Linked Incentive... Read more |
|
|
Empowering India's Pharma Industry: The Strategic Impact of PLI InitiativesIn recent years, India's pharmaceutical industry has undergone a remarkable transformation, fueled by the implementation of Production Linked Incentive... Read more |
|
|
Empowering India's Pharma Industry: The Strategic Impact of PLI InitiativesIn recent years, India's pharmaceutical industry has undergone a remarkable transformation, fueled by the implementation of Production Linked Incentive... Read more |
|
|
Empowering India's Pharma Industry: The Strategic Impact of PLI InitiativesIn recent years, India's pharmaceutical industry has undergone a remarkable transformation, fueled by the implementation of Production Linked Incentive... Read more |
|
LCA Analysis in the Pharmaceutical IndustryTracking down emissions Identifying potential savings is like finding the proverbial needle in a haystack: it isn’t easy, but it isn’t impossible... Read more |
|
Critical Fluid Transfer Applications in Biopharmaceutical IndustryAs a definition, any biological macromolecule or cellular component that is able to exert or enhance a therapeutic, curative or protective property can be considered... Read more |
Interviews
|
Revolutionizing Drug Delivery with Gattefosse Innovative Lipid-Based ExcipientsQ: What differentiates Gattefossé’s pharmaceutical excipients from those of its competitors in the global market? At Gattefossé, we provide... Read more |